ONCO Oncology Med Inc.
Oncology Med Inc. (ONCO) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 0% planned / 100% discretionary
Largest single sale: $70.8K.
Where they traded
Last open-market purchase: April 17, 2026 , by HRT FINANCIAL LP .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| HRT FINANCIAL LP | 10% Owner | Sell | 49,710 | $0.69 | $34.3K | 33,649 −59.6% of holding | |
| HRT FINANCIAL LP | 10% Owner | Sell | 94,462 | $0.75 | $70.8K | 83,359 −53.1% of holding | |
| HRT FINANCIAL LP | 10% Owner | Buy | 34,636 | $0.73 | $25.3K | 177,821 | |
| HRT FINANCIAL LP | 10% Owner | Sell | 53,867 | $0.73 | $39.3K | 143,185 −27.3% of holding | |
| HRT FINANCIAL LP | 10% Owner | Buy | 92,554 | $0.76 | $70.3K | 197,052 | |
| HRT FINANCIAL LP | 10% Owner | Buy | 74,350 | $0.77 | $57.2K | 104,498 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.